Nexvet Biopharma (NVET) Tops Q1 EPS by 4c

Nexvet Biopharma (NASDAQ: NVET) reported Q1 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Nexvet Biopharma (NVET) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
• Marvell Technology (MRVL) Tops Q2 EPS by 1c, Offers Guidance